ABSTRACT-The inhibitory effects of calcium antagonists on high-potassium or glutamate (Glu) enhanced intracellular calcium ion ([Ca2+];) levels were studied in cultured cerebellar granule cells. Dosages between 0.5 and 10 pM of flunarizine, nicardipine, SM6586 and SM12565 reduced the rise in [Ca 211i induced by 50 mM KC1 in a dose-dependent manner, although diltiazem, verapamil and nifedipine showed less effects on such [Ca 21]i increases. SM6586, SM12565 and flunarizine at dosages below 10 uM each reduced the magnitude of the [Ca2+]; increase induced by 25 pM Glu, but the other examined calcium antagonists were less effective. These results suggest the dissimilar efficacy of calcium antagonists on the inhibition of [Ca 21]i levels increased by high-potassium and Glu.
Some calcium antagonists have been reported to pre vent the neuronal damage of ischemia in vivo (1, 2) . The prevention of neuronal dysfunction by these antagonists were explained as follows: A) they could increase the cerebral blood flow through a direct action on the cerebral vessels and B) they could reduce the entry of Ca 21 into the cell by blocking the voltage-sensitive cal cium channels (VOC). Furthermore, studies on the mecha nism of neuronal death suggest that ischemia/hypoxia induced neuronal death is due to the release of glutamate (Glu) from brain tissue during hypoxia, and the excessive extracellular accumulation of Glu results in a Ca 21 over load which leads to neuronal degeneration (3 5) . For these reasons, the direct effects of calcium antagonists which block the VOC and/or receptor operated calcium channel (ROC) may be beneficial and expected to improve the neuronal dysfunction either by blocking [Ca 21]i in crease or modulating Glu release (6) .
In this experiment, we compared the direct inhibitory effects of flunarizine, nicardipine, nifedipine, SM12565, SM6586, diltiazem and verapamil on both the high-potas sium and Glu induced increase in [Ca 21]i levels in cul tured rat cerebellar granule cells to determine their effects and potential on VOC and ROC in central neurons.
Cultured cells were prepared by our previously described method (7), which was slightly modified from the method of Gallo et al. (8) . Briefly, 10 cerebella from 8-day-old Wistar rats were dissected and chopped into 400-um blocks. Cells were isolated by mild trypsinization (0.025%, trypsin) followed by trituration in a DNAase so lution (0.0008%) with a trypsin inhibitor (0.004%). Final ly, the cells were suspended in Modified Basal Eagle Medi um (Kyokuto Pharm. Ind. Co., Ltd., Tokyo), containing 10% fetal bovine serum (Bocknek, Toronto, Canada), 25 mM KCI, 4 mM glutamine and 0.2% gentamycin, at a density of 1.25 x 106 cells/ml. Then a 2-ml aliquot of the cell suspension was put into each 35-mm culture dish con taining a coverslip glass (¢25 mm) coated with 20 ug/ml poly-L-lysine. Fifty microliters of cytosine arabinoside (final concentration of 10 pM) was added to each culture in 16 hr to prevent non-neuronal cell proliferation. Cul tures were incubated at 37V in a humidified atmosphere containing 5% CO2 for 3 to 5 days in vitro before use. The alteration of [Ca 21]i was measured with a fluorescent Ca2+ indicator, Fura-2, as reported previously (9) . The coverslip glass containing granule cells was washed twice with Krebs' HEPES (KH) buffered solution (136 mM NaCI, 10 mM glucose, 20 mM HEPES, 5 mM KCI, 2 mM CaC12, 1.3 MM MgC12, and sufficient NaOH bring the pH to 7.4). Then cells were incubated in 5 1M Fura-2AM (Dojin Chem., Ltd., Kumamoto) in KH for 45 min at 37C. Loaded cells were then transferred into the measuring chamber of the fluorimeter (CAF-100, Jasco, Tokyo) and were superfused with KH (1 ml/min at 37C). A group of cells was alternately illuminated with 340/380 nm excitation, emitted light was collected at 500 nm, and the fluorescence was monitored and recorded by means of a PC-9801 personal computer (NEC, Tokyo) with CAF-200 software (Jasco). The value of [Ca 21]i was determined by the following formula as described by Grynkiewicz et al. (10):
The values for Rmax, Rmin and FO/FS were obtained by measuring the fluorescence of 20 pM Fura-2 in a solution of 150 mM KC1, 10 mM HEPES, 2 mM MgSO4, 10 MM EGTA, and sufficient NaOH to bring the pH to 7.1. Rmin was the 340/380 ratio without added calcium; Rmax was the ratio when saturating calcium, 15 mM, was added; FO/FS was the 380 nm intensity in saturating calcium, and the Kd for Fura-2 was 224 nM (10) .
We initially examined the effects of either high-potas sium or Glu on In this experiment, we chose 50 mM KC1 and 25 pM Glu as the stimulating agents and com pared the inhibitory effects of the examined calcium an tagonists at a series of concentrations on the [Ca 211i in crease induced by 50 mM KC1 or 25 pM Glu. Calcium an tagonists were dissolved in dimethyl sulfoxide at 10 mM and then were diluted in KH to the desired concentration. All the examined doses of the calcium antagonists were identified as having no effect on the resting [Ca 2+]i and no effect on the fluorescence of Fura-2. Figs. 1 and 2) . The inhibitory effects on 50 mM KCI or 25 uM Glu increased [Ca 211i levels in cultured cerebellar granule cells are represented by the solid columns and oblique columns, respectively. Each data shows the mean ±S.E.M. of 3 to 6 separate experiments (each experiment consisted of one culture dish). Ten micromolar nicardipine, SM6586 and SM 12565 each inhibited more than 80% of the increase in [Ca 2+]i levels by 50 mM KC1, although 100 pM nifedipine only caused about a 43% inhibition of this rise (Fig. 1) . In the case of the 25 pM Glu-induced [Ca 21]i increase, dosages from 1 to 10 pM of SM6586 and SM 12565 showed a similar inhibitory potency as with 50 mM KCI; however, 500 pM nicardipine caused a 30% inhibition of such an increase. Unlike the case of the 50 mM KC1 induced [Ca 211i increase, 10 pM nifedipine was found to inhibit the 25 pM Glu-enhanced [Ca 21]i increase, and 50 pM nifedipine showed about 50% inhibition of the [Ca 2+]i increase (Fig. 1) . In Fig. 2 The present data suggest that the pharmacological potency of the examined calcium antagonists are different from the order that is seen in the peripheral nervous sys tem (11, 12) and clearly different from the cardiac circula tory system (9, 11 13) . This might be explained by differ ences between the calcium channels in the neurons com pared to those of other cells (14) . However, the present results also indicate that calcium antagonists, for exam ple, even the similar 1,4-DHP derivatives, SM6585, SM12565, nicardipine and nifedipine, produce different pharmacological potentiation on VOC and ROC in the central nervous system. Whether or not these differences are due to the different binding affinities of these an tagonists is yet to be identified. Additionally, the novel 1,4-DHPs, SM6586 and SM12565, were reported to have less effect on the cardiac blood system (13), but in this experiment, they effectively inhibited not only VOC but also ROC in cultured cerebel lar granule cells in a dose-dependent manner. These data indicate that SM6586, SM12565 and flunarizine have the same efficacy for the protection against increased [Ca2+], levels produced by high-potassium or excessive amounts of Glu.
